Q3 2025 Zai Lab Ltd Earnings Call Transcript

Nov 6, 2025 / 01:00 PM GMT

Release Date Price: $23.15 (-6.65%)

Transcript 10-Q8-K

Key Points

Positve

Zai Lab Ltd (ZLAB) reported a 14% year-over-year revenue growth, reaching $116 million in Q3 2025.
The company is on track for its first global approval of ZL 1,310 (Zozi) by 2027 or early 2028, with promising data in small cell lung cancer.
Zai Lab Ltd (ZLAB) has a commercially profitable business in China, with a strong commercial team and differentiated high-potential assets.
The company is advancing its global pipeline rapidly, with several innovative programs in oncology and immunology.
Zai Lab Ltd (ZLAB) maintains a strong financial foundation, ending the quarter with $817 million in cash, providing flexibility for future investments.

Negative

The pace of market build for Vivguard in China has been slower than initially anticipated, affecting revenue expectations.
Zai Lab Ltd (ZLAB) revised its full-year revenue guidance to at least $460 million, reflecting slower growth in some areas.
The company faces supply constraints for certain products, impacting its ability to meet demand fully.
Despite being commercially profitable in China, the overall pace of growth has been slower due to a complex and dynamic environment.
Zai Lab Ltd (ZLAB) expects profitability to shift beyond the fourth quarter, reflecting a lower revenue base this year.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

9688.HK - Zai Lab Ltd
Q3 2025 Zai Lab Ltd Earnings Call
Nov 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hello ladies and gentlemen.

Thank you for standing by and welcome to Zy Labs 3rd quarter 2025 financial results conference call.

At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session.

And instructions will follow at the time. As a reminder, today's call is being recorded.

It is now my pleasure to turn the floor over to Christine Chou, senior Vice President of Investor Relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Hello and welcome, everyone. Today's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.